Sathgen Therapeutics announces dosing of the first patient cohort with MSP008-22, a novel anti-cancer drug
/PRNewswire/ -- Sathgen Therapeutics, a division of a leading chemicals conglomerate in India – Godavari Biorefineries Limited (GBL), has announced the...
Source: prnewswire.com